Xcout Intel
Lighthouse Pharma
Lighthouse Pharma is a clinical-stage private biopharmaceutical company that specializes in precision medicine approaches targeting major unmet medical needs. The company is headquartered at the Buck Institute for Research on Aging in California.
Subscribe to see Lighthouse Pharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Lighthouse Pharma at a glance
Lighthouse Pharma is a drug discovery company headquartered in United States. It has raised at least $61.2M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $12M in April 2026. Xcout tracks 1 named person at Lighthouse Pharma, including Casey Lynch (Chief Executive Officer).
Lighthouse Pharma leadership
- Casey LynchChief Executive Officer
Lighthouse Pharma funding rounds
At least $61.2M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $12M | 1 named | |
| Series A | $49.2M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Lighthouse Pharma competitors
A few of Lighthouse Pharma's closest competitors — see the full list of competitors and alternatives →
Enlaza Therapeutics, Inc. is a biotechnology enterprise headquartered in California, United States. The company designs and develops next-generation covalent biologic therapeutics targeting serious diseases. It utilizes specialized proprietary discovery platforms to advance precision medicine applications.
Retro Biosciences is a biotechnology research company based in Redwood City, California, that develops therapies targeting aging biology. Its goal is to extend healthy human lifespan by 10 years.
Retrotope, Inc. is a drug development company headquartered in Los Altos, California, focused on creating therapeutics for degenerative diseases.
Gero is a biotechnology company headquartered in Singapore with a U.S. subsidiary, combining physics, biology, and artificial intelligence to decode human biology and develop life-changing medicines.
Get Lighthouse Pharma's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Lighthouse Pharma in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access